Inhibrx Biosciences, Inc. (INBX)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
124. 66
-2.04
-1.6101%
After Hours
$
+8.39 +6.7303% 133. 05
1.81B Market Cap
- P/E Ratio
- Div Yield
275,590 Volume
-4.39 Eps
$ 126.7
Previous Close 
Want to track INBX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Inhibrx Biosciences, Inc. (INBX) Statistics
Valuation metrics
Market Cap 1.81B
Enterprise value 1.68B
Trailing P/E (ttm) -13.9
Forward P/E -41.63
PEG ratio -0.75
Price/Sales (ttm) 1,000.57
Price/Book (mrq) -36.5
Enterprise Value/Revenue 880.76
Enterprise Value/EBITDA -13.97
Overview
Shares outstanding 14.58M
Float 7.81M
Shares short 2.73M
% Held by insiders 0.23%
% Held by institutions 0.82%
Average volume (10 days) 241.48K
Average volume (90 days) 379.7K
Price summary
52-Week low 26.19
52-Week high 155.29
Beta -
50-Day moving average 103.47
200-Day moving average 89.86
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 20 Jun 2024
Ex-Dividend Date 30 May 2024
Last split factor -
Last split Date -
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -100.14%
Operating margin -94.65%
Operational effectiveness
Return on assets -0.9%
Return on equity 18.94%
Income Statement
Revenue (ttm) 1.3M
Revenue per share (ttm) 0.08
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) -111.73M
EBITDA -132.54M
Net income to common (ttm) -140.06M
Diluted EPS (ttm) -8.82
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 124.22M
Total cash per share (mrq) 8.51
Total debt (mrq) 107.01M
Total Debt/Equity (mrq) -0.1
Current ratio (mrq) 5.07%
Book value per share (mrq) -3.38
Cash Flow
Cash flow statement -129.79M
Levered free cash flow (LFCF) -84.46M
